中文版English

Home | Add to Favorites | Contact Us

Home >> Enterprises >> Beijing Collab Pharma Co. Ltd.

 

Founded in 1996 as the only national new medicine development center by the National Department of Science and Technology of China, the National Research Center for Engineering and Technology of New Medicine Development is engaged in research and development of new medicines, including application, technology and marketing.        
Beijing Collab Company formerly known as the National Research Center was incorporated and began public operation in 2002. It is based in Beijing as a specialty research facility for medicinal development. The facility and operation are overseen by the Institute of Materia Medica, Chinese Academy of Medicinal Sciences, with purposes to: search new pathways for technology and marketing integration; scale up laboratory work to industrial production; develop technological platforms with international guidelines for new drugs; offer services to domestic trades.       
In the past decade since the transformation from the National Research Center, the company received strong support from Department of Science and Technology, Department of Public Health, the local government also Institute of Materia Medica, Chinese Academy of Medicinal Science.         
A new research system for pharmaceutical engineering and the corresponding pilot operation for factory production have been established. Three factory bases with different applications are remotely located over China; a series of scale up production studies can be achieved.
"Honesty, collaboration, investigation and creation" are the spirit of Collab. The character of this spirit is the assumption of social responsibility, the liability to our investors, shareholders, and the obligation to our employees, the perfectness to customers and the involvement to environment protection and sustainable development. Obeying this enterprise spirit, exchanges, cooperation and mutual benefit should be the defining features of our company. In a way to our mutual understanding and cooperation, the both sides, our partner and the company, can achieve win-win progress and make greater joint efforts for the development of pharmaceutical research and industry in China.
 
 

【Back】